Skip to main content
Clinical Trials/KCT0007397
KCT0007397
Not yet recruiting
未知

Comparison between abluminal biodegradable polymer ultrathin sirolimus-eluting stent and durable-polymer everolimus-eluting stent (GENOSS randomized clinical trial)

Samsung Medical Center0 sites850 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Samsung Medical Center
Enrollment
850
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? 19 years of age or older
  • ? Patients diagnosed with stable coronary artery disease or acute coronary syndrome and with more than 50% coronary stenosis requiring stent insertion
  • ? A person who can voluntarily sign the consent form

Exclusion Criteria

  • ? If the following drugs are irritable or contraindicated (aspirin, clopidogrel, ticagrelor, prasugrel, heparin, sirolimus, or everolimus)
  • ? a pregnant woman
  • ? A person who is expected to have a life expectancy of less than one year due to non\-heart disease or less compliant with treatment (as determined by medical judgment by the investigator)
  • ? Patients who refused to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials